Gestational Diabetes Collaborative
The Gestational Diabetes Collaborative is a partnership with CDC/Division for Diabetes Translation to support a multi-state collaboration to develop and implement strategies to improve quality of routinely collected GDM data, improve the level of awareness that women with a history of GDM are at substantially increased risk for future development of type 2 diabetes, and implement strategies to enhance postpartum glucose testing and follow-up.
- Gestational Diabetes: Public Health Concerns
- Gestational diabetes mellitus (GDM) is defined as carbohydrate intolerance of variable severity, with onset or first recognition during pregnancy. For the woman, GDM complicates 3-14% of pregnancies in the United States, and it is responsible for an important maternal morbidity including pregnancy induced high blood pressure, preeclampsia, urinary tract infections, cesarean delivery and other issues. GDM is on the rise in the US and is now estimated to affect 4-6% of all pregnancies. The consequences for the woman is a greater risk (7 fold) for developing types 2 diabetes later in life. For the child, the issues are macrosomia, birth trauma, hyperglycemia at birth. The consequences for the child are a greater risk of developing type 2 diabetes later in life.
- This Guidelines folder includes international, national, state and organization recommendations on screening, diagnosing, managing/treating and post partum follow-up for women with Gestational Diabetes
- The Resources folder contains GMD clinical materials, literature updates, links and other information helpful for public health practitioners
- State Partners
- This State Partners folder contains information related to the Gestational Diabetes Collaborative Network.
- The events folders contains information on national, state and local conferences and network schedule of conference calls.